effectiveness of Venlafaxine and Duloxetine on peripheral neuropathy caused by chemotherapy
Phase 2
- Conditions
- pripheral neuropathy.Drug-induced polyneuropathy
- Registration Number
- IRCT2015060922632N1
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 156
Inclusion Criteria
Inclusion criteria were: Patients with cancer and with peripheral neuropathy caused by chemotherapy; Patient written consent; No uncontrolled blood pressure, diabetes, addiction.
Exclusion criteria: Patients treated with tamoxifen; Incidence of intolerable side effects; No on time and correct use of medicines; No patient cooperation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of neuropathy. Timepoint: The first, second week and end of the study (fourth week). Method of measurement: Based on the visual analogue scale (VAS), Sheehan Disability Scale, Brief Pain Inventory, Depression Inventory (Mood), Beck Depression Inventory (BD1-11), Clinical Global Impression Scale.
- Secondary Outcome Measures
Name Time Method